PHR
Phreesia Inc.
$15.65
-$0.13(-0.82%)
48
Overall
50
Value
36
Tech
60
Quality
Market Cap
$1.33B
Volume
1.30M
52W Range
$18.55 - $32.76
Target Price
$33.60
Company Overview
| Mkt Cap | $1.33B | Price | $15.65 |
| Volume | 1.30M | Change | -0.82% |
| P/E Ratio | -22.8 | Open | $15.90 |
| Revenue | $419.8M | Prev Close | $15.78 |
| Net Income | $-58.5M | 52W Range | $18.55 - $32.76 |
| Div Yield | N/A | Target | $33.60 |
| Overall | 48 | Value | 50 |
| Quality | 60 | Technical | 36 |
No chart data available
Latest News
Canaccord Genuity Sticks to Its Buy Rating for Phreesia (PHR)
TipRanks Auto-Generated Intelligence Newsdesk•3 days ago
Phreesia Reports Strong Q3 2026 Earnings and Positive Outlook
TipRanks Auto-Generated Newsdesk•3 days ago
PharmaTher Sells Ketamine ANDA to Focus on Long-Acting Injectable Program
TipRanks Canadian Auto-Generated Newsdesk•10 days ago
Canaccord Genuity Keeps Their Buy Rating on Phreesia (PHR)
TipRanks Auto-Generated Intelligence Newsdesk•10 days ago
PharmaTher Secures Rights to Long-Acting Ketamine Program for Neuropsychiatric Disorders
TipRanks Canadian Auto-Generated Newsdesk•25 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PHR | $15.65 | -0.8% | 1.30M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |